Cryo Cell International (CCEL) Return on Capital Employed (2011 - 2026)

Cryo Cell International (CCEL) has 16 years of Return on Capital Employed data on file, last reported at 0.44% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 0.44%, down 148.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.44% (down 148.0% YoY), and the FY2025 annual result was 1.11%, down 26.0% from the prior year.
• Return on Capital Employed eased to 0.44% in Q1 2026 per CCEL's latest filing, from 1.13% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 3.17% in Q3 2025 and troughed at 30.04% in Q1 2024.
• A 5-year average of 5.71% and a median of 1.4% in 2024 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2024 and 2025: Return on Capital Employed slumped 3200 bps in 2024, then surged 3216 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 1.5% in 2022, then sank by 1864 bps to 26.53% in 2023, then surged by 105 bps to 1.4% in 2024, then retreated by 19 bps to 1.13% in 2025, then tumbled by 61 bps to 0.44% in 2026.
• Business Quant data shows CCEL's Return on Capital Employed at 0.44% in Q1 2026, 1.13% in Q4 2025, and 3.17% in Q3 2025.